AstraZeneca plans to develop treatment options for people with different BMIs as part of its “very ambitious” obesity strategy.
AstraZeneca CEO Pascal Soriot on Thursday …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Bristol Myers Squibb dropped another CTLA-4 program from its decade-long research collaboration with CytomX after the big pharma reviewed its portfolio. CytomX announced the change
Researchers analyzed genetic underpinnings of biological age gaps in nine organ systems using a large dataset from the U.K. Biobank, revealing organ-specific yet interconnected genetic
The effects of academic performance on the association between e-cigarette use and social media influence.